Nanoparticles can be used in many ways as catalysts. To be able to tailor them in such a way that they can catalyse certain reactions selectively and efficiently, researchers need to determine the properties of single particles as precisely as possible. So far, an ensemble of many nanoparticles is analysed. However, the problem of these investigations is that the contributions of different particles interfere, so that the properties of individual particles remain concealed. Researchers at Ruhr-Universiät Bochum in cooperation with colleagues from University of Duisburg-Essen and Technical University of Munich have developed a novel method in order to observe single nanoparticles before, during and after an electrochemical reaction. They depict the process in the journal Angewandte Chemie, published on 16 April 2019.
Observing the complete lifecycle
“To comprehensively understand the catalytic activity of a nanoparticle, we have to observe how its structure and composition change – from the pre-catalyst to the active catalyst and eventually all the way to the condition after the reaction,” explains Professor Wolfgang Schuhmann, head of the Center for Electrochemical Sciences. “This is why we have developed the particle at the stick.”
The researchers grew a catalyst nanoparticle at the tip of a carbon nanoelectrode, subsequently activated it and used it to catalyse an electrochemical reaction. Unlike previous approaches, the novel method made it possible for the team to observe the complete lifecycle of the particle.
Fabricating the particle at the stick
In the first step, the chemists modified the carbon nanoelectrode such that the particle preferably attaches to the tip of the electrode. Subsequently, they dipped the electrode’s tip into a solution, which contained the precursor materials for the catalyst. After that, these components assembled automatically, ultimately producing a symmetric particle, in which the constituting elements – the metal cobalt as well as the organic carbonaceous components – were evenly distributed.
Image Credit: RUB, Marquard
News This Week
Within a day of testing positive for covid-19 in June, Miranda Kelly was sick enough to be scared. At 44, with diabetes and high blood pressure, Kelly, a certified nursing assistant, was having trouble [...]
A technology developed at Vanderbilt University Medical Center has led to the discovery of an "ultra-potent" monoclonal antibody against multiple variants of SARS-CoV-2, the virus responsible for COVID-19, including the delta variant. The antibody [...]
Research has found a significant fall in levels of antibodies against SARS-CoV-2, the virus that causes COVID-19, 6 months after the second dose of the Pfizer-BioNTech vaccine. Clinical evidence also suggests that the risk [...]
Are the COVID vaccines substantially different from/inferior to other vaccines in terms of their effectiveness? The issue raised, and I'm mostly paraphrasing here, is this: Most vaccines (e.g. measles, smallpox) have efficacy defined such [...]
The EVONANO platform allows scientists to grow virtual tumors and use artificial intelligence to automatically optimize the design of nanoparticles to treat them. The ability to grow and treat virtual tumors is an [...]
Modern Approaches to Augmentation of Brain Function Available from Springer Press This book covers recent advances in neural technology that provide for enhancements for brain function. It addresses a broad range of neural phenomena [...]
Although the currently available COVID-19 vaccines are highly effective, limited manufacturing capacity and the need for cold-chain storage hinder their global distribution. A recent study tested the efficacy of a new adeno-associated virus (AAV) [...]
Fully vaccinated people were 11 times less likely to die of COVID and 10 times less likely to be hospitalized compared to the unvaccinated since highly contagious Delta became the most common variant, US [...]
The highly-infectious Delta coronavirus variant has spread to at least 174 countries worldwide, from the US to Australia, causing a surge in COVID-19 cases. The variant has mutations that help it partially escape the immune response produced by [...]
Fragile mRNA molecules used in COVID-19 vaccines can’t get into cells on their own. They owe their success to lipid nanoparticles that took decades to refine. Messenger RNA (mRNA) is having a moment. This [...]
The COVID-19 pandemic has revealed critical knowledge gaps and assumptions concerning how respiratory viruses spread between hosts. Traditionally thought to be spread mainly through large respiratory droplets produced by the coughs and sneezes of sick individuals, [...]
SARS-CoV-2 is just one of nonillions of viruses on our planet, and scientists are rapidly identifying legions of new species. Mya Breitbart has hunted novel viruses in African termite mounds, Antarctic seals and water [...]
As a team of South African researchers we have identified a new lineage of SARS-CoV-2, the virus causing COVID-19. A lineage represents a genetically distinct virus population with a common ancestor. This virus may be designated as a variant [...]